Effluent from ischemic preconditioned hearts confers cardioprotection independent of the number of preconditioning cycles

PLoS One. 2020 Dec 3;15(12):e0243220. doi: 10.1371/journal.pone.0243220. eCollection 2020.

Abstract

Coronary effluent collected from ischemic preconditioning (IPC) treated hearts induces myocardial protection in non-ischemic-preconditioned hearts. So far, little is known about the number of IPC cycles required for the release of cardioprotective factors into the coronary effluent to successfully induce cardioprotection. This study investigated the cardioprotective potency of effluent obtained after various IPC cycles in the rat heart. Experiments were performed on isolated hearts of male Wistar rats, mounted onto a Langendorff system and perfused with Krebs-Henseleit buffer. In a first part, effluent was taken before (Con) and after each IPC cycle (Eff 1, Eff 2, Eff 3). IPC was induced by 3 cycles of 5 min of global myocardial ischemia followed by 5 minutes of reperfusion. In a second part, hearts of male Wistar rats were randomized to four groups (each group n = 4-5) and underwent 33 min of global ischemia followed by 60 min of reperfusion. The previously obtained coronary effluent was administered for 10 minutes before ischemia as a preconditioning stimulus. Infarct size was determined at the end of reperfusion by triphenyltetrazoliumchloride (TTC) staining. Infarct size with control effluent was 54±12%. Effluent obtained after IPC confers a strong infarct size reduction independent of the number of IPC cycles (Eff 1: 27±5%; Eff 2: 35±7%; Eff 3: 35±8%, each P<0.05 vs. Con). Effluent extracted after one cycle IPC is comparably protective as after two or three cycles IPC.

MeSH terms

  • Animals
  • Cardiotonic Agents / pharmacology*
  • Heart / physiopathology
  • Ischemic Preconditioning, Myocardial / methods*
  • Male
  • Myocardial Infarction / prevention & control
  • Myocardial Ischemia / metabolism*
  • Myocardial Ischemia / physiopathology
  • Myocardial Reperfusion Injury / prevention & control
  • Myocardium
  • Rats
  • Rats, Wistar

Substances

  • Cardiotonic Agents

Grants and funding

The authors received no specific funding for this work.